Lithium Carbonate
NDC 68151-0639
Product Information
Lithium Carbonate is a ANDA-approved product labeled by Carilion Materials Management. This medication is used to treat manic-depressive disorder (bipolar disorder). It is supplied as a brown product. This product entry covers the primary NDC 68151-0639 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
54;107
Code Structure Chart
Product Details
What is NDC 68151-0639?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LITHIUM CARBONATE (UNII: 2BMD2GNA4V)
- LITHIUM CATION (UNII: 8H8Z5UER66) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CALCIUM STEARATE (UNII: 776XM7047L)
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SORBITOL (UNII: 506T60A25R)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- POLYDEXTROSE (UNII: VH2XOU12IE)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 197891 - lithium carbonate 300 MG Extended Release Oral Tablet
- RxCUI: 197891 - LiCO3 300 MG Extended Release Oral Tablet
* Please review the full disclaimer at the bottom of this page.